Masimo Corporation

NasdaqGS:MASI Stock Report

Market Cap: US$9.0b

Masimo Past Earnings Performance

Past criteria checks 0/6

Masimo's earnings have been declining at an average annual rate of -32.6%, while the Medical Equipment industry saw earnings growing at 15.1% annually. Revenues have been growing at an average rate of 17.9% per year.

Key information

-32.6%

Earnings growth rate

-32.4%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate17.9%
Return on equity-29.0%
Net Margin-14.6%
Next Earnings Update06 May 2025

Recent past performance updates

Recent updates

Masimo: Priced Dearly Given Uncertainty

Apr 25

Pinning Down Masimo Corporation's (NASDAQ:MASI) P/S Is Difficult Right Now

Apr 24
Pinning Down Masimo Corporation's (NASDAQ:MASI) P/S Is Difficult Right Now

An Intrinsic Calculation For Masimo Corporation (NASDAQ:MASI) Suggests It's 34% Undervalued

Feb 17
An Intrinsic Calculation For Masimo Corporation (NASDAQ:MASI) Suggests It's 34% Undervalued

At US$178, Is Masimo Corporation (NASDAQ:MASI) Worth Looking At Closely?

Jan 30
At US$178, Is Masimo Corporation (NASDAQ:MASI) Worth Looking At Closely?

Masimo: A Stellar Performance After The Dust Has Settled

Dec 11

Here's Why Masimo (NASDAQ:MASI) Has A Meaningful Debt Burden

Nov 28
Here's Why Masimo (NASDAQ:MASI) Has A Meaningful Debt Burden

Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 44% Undervaluation?

Nov 07
Is There An Opportunity With Masimo Corporation's (NASDAQ:MASI) 44% Undervaluation?

Masimo Corporation's (NASDAQ:MASI) 28% Share Price Surge Not Quite Adding Up

Oct 15
Masimo Corporation's (NASDAQ:MASI) 28% Share Price Surge Not Quite Adding Up

Masimo Corporation: Too Much Uncertainty For Now

Sep 25
author-image

Sensors Surge And Decisive Shifts Set To Soar In Healthcare Triumph

Aug 28 Increased hospital admissions and successful hospital conversions to Masimo products are anticipated to continue driving healthcare revenue growth.

What Is Masimo Corporation's (NASDAQ:MASI) Share Price Doing?

Aug 01
What Is Masimo Corporation's (NASDAQ:MASI) Share Price Doing?

Masimo Corporation's (NASDAQ:MASI) Share Price Matching Investor Opinion

Jul 11
Masimo Corporation's (NASDAQ:MASI) Share Price Matching Investor Opinion

These 4 Measures Indicate That Masimo (NASDAQ:MASI) Is Using Debt Extensively

Jun 19
These 4 Measures Indicate That Masimo (NASDAQ:MASI) Is Using Debt Extensively

Masimo: Promising Developments

May 12

Analyst Estimates: Here's What Brokers Think Of Masimo Corporation (NASDAQ:MASI) After Its First-Quarter Report

May 10
Analyst Estimates: Here's What Brokers Think Of Masimo Corporation (NASDAQ:MASI) After Its First-Quarter Report

Baron Funds - Masimo Corp.: Can Potentially Double Our Investment

May 05

Masimo: Given The Lack Of Improvement In Revenues And Margins, It Is A Little Expensive

Feb 18

Revenue & Expenses Breakdown

How Masimo makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NasdaqGS:MASI Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
28 Dec 242,094-305754223
28 Sep 242,04379710183
29 Jun 242,01779671181
30 Mar 241,97679645173
30 Dec 232,04882664175
30 Sep 232,11689690192
01 Jul 232,187116707198
01 Apr 232,297118728206
31 Dec 222,036144641191
01 Oct 221,746171559170
02 Jul 221,505191487153
02 Apr 221,244223408139
01 Jan 221,239230395137
02 Oct 211,207232382136
03 Jul 211,177224371129
03 Apr 211,173229376126
02 Jan 211,144240369119
26 Sep 201,096223361110
27 Jun 201,047222351106
28 Mar 2097621133099
28 Dec 1993819631593
28 Sep 1991319030691
29 Jun 1989519829787
30 Mar 1987719728983
29 Dec 1885819428581
29 Sep 1884313929076
30 Jun 1882611828471
31 Mar 1880711928067
30 Dec 1779012527365
30 Sep 1776634827160
01 Jul 1774034026361
01 Apr 1772032526059
31 Dec 1671331125558
01 Oct 1667210925558
02 Jul 1665710125757
02 Apr 166409025455
02 Jan 166238325356
03 Oct 156238024458
04 Jul 156137624658
04 Apr 155967024658
03 Jan 155807324157
27 Sep 145566123555
28 Jun 145456122655

Quality Earnings: MASI is currently unprofitable.

Growing Profit Margin: MASI is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: MASI is unprofitable, and losses have increased over the past 5 years at a rate of 32.6% per year.

Accelerating Growth: Unable to compare MASI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MASI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.2%).

Return on Equity

High ROE: MASI has a negative Return on Equity (-28.99%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/04 02:23
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/28
Annual Earnings2024/12/28

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Masimo Corporation is covered by 31 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael PolarkBaird
Ishan MajumdarBaptista Research
Charley JonesBarrington Research Associates, Inc.